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COVID-19 acute aortopathiesThe interesting article by Katsarou et al1 about aortic
intramural hematoma complicating a severe acute respi-
ratory disease coronavirus 2 (SARS-CoV-2) infection isFig. A, Leukocytoklastic vasculitis with neutrophils infi
adventitia of the abdominal aorta (stain: hematoxylin an
tochemistry for CD61: platelets interaggregate inside an o
(arrow 1) and adhere to the endothelial cells (arrow 2)
Schematic flow chart: a cascade of vascular events triggecompelling, and its pathophysiology needs to be eluci-
dated further.
We consider the promoting factors of coronavirus dis-
ease 2019 (COVID-19) to be the high number of
angiotensin-converting enzyme 2 receptors present in
the aortic walls. These receptors directly bind COVID-19
virions and lead to abnormal apoptosis of endothelial
cells.2 This process can explain the direct onset of the
rare acute aortitis associated with COVID-19.3 For other
vasculardmainly aorticdcomplications of SARS-CoV-2
infection, we emphasize the important role of the sec-
ondary damage to the vasa vasorum (VV), which begins
with an acute lymphocytic endotheliitis. As in other cap-
illaries and arterioles, it consists of a diffuse endothelialltration and karyorrhexis in the tunica media and
d eosin; original magnification 10). B, Immunohis-
cclusive thrombosis of an external vasa vasorum (VV)
(2f2 clone, 10). (Modified from Roncati L, et al.5).
red by coronavirus disease 2019 (COVID-19).
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trophils, followed by accelerated pyroptosis and throm-
bosis. This pathology can further evolve through
activated B lymphocytes that generate plasma cells, in
turn leading to a deposition of polyclonal immune com-
plexes and complement fractions in vessels walls.
This immunocomplex-mediated peri/pan-arteritis,
evident on histology with neutrophil infiltration and
accumulation of fibrinoid materials, seems to be a
more severe leukocytoclastic vasculitis (Fig, A).4 The asso-
ciated inflammatory state causes an increased release of
cytokines, typically interleukin-6, and, at the same time,
recruitment of platelets to perform, in agreement with
their myeloid lineage, a covercytosis against the virions.
Moreover, platelets strictly adhere to damaged endo-
thelia and surround the fibrin aggregates. Newly
manufactured antiphospholipid antibodies, as in a sec-
ondary antiphospholipid-like syndrome, favor, together
with the basic COVID-19 procoagulative state, local
thromboses, that acquire the particular feature of
immunothrombosis.
In medium and large arteries, this pathology involves
the external VV as well, while the internal VV, because
of their small caliber, thinner walls, and lower blood
inflow, disappear as a direct result of the antecedent
endothelial damage (Fig, B).5 As shown,6 the subsequent
hypoxia in arterial walls produces hypoxia-inducible
factor 1a, in turn releasing other substances, such as
matrix metalloproteinases, macrophages, monocytes,
and chemoattractant proteins, specific for secondary
degenerative-inflammatory lesions. In addition to
endothelin-1 and angiotensin II type 1, vasoconstrictors
are active on the VV as well.6 This process worsens the
local preinflammatory or inflammatory conditions,
already promoted by preexisting endothelial dysfunc-
tion, increases the degradation of collagen and elastic fi-
bers, and greatly decreases the population of smooth
muscle bundles in the media layer. In the VV, we have
to consider, as an additional functional factor hampering
blood inflow, their radial or circumferential external
compression by inelastic atherosclerotic vessels, mainly
when stressed by arterial hypertension. This cascade of
pathological events directly explains the pathogenesis
of penetrating endothelial ulcers that connect with the
entire group of acute aortopathies associated with
COVID-19, including mural thrombosis, intramural hema-
toma, and dissection (Fig). In contrast, the acute or
subacute development of an aneurysm, which is in this
case inflammatory, hypothesized to be caused by the
decreased elasticity and increased fragility of the aortic
walls, has not yet been reported.7 This unified
anatomo-clinical notion of acute aortopathies, including
different pathologies with reciprocal connections, fits
well with the wide spectrum of COVID-19 features and
prompts research on this disease complications, which
may be otherwise overlooked.Luca Roncati, MD
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https://doi.org/10.1016/j.jvs.2021.07.131ReplyWe thank Dr Roncati for reading and commenting1
on our case reporting an acute aortic intramural he-
matoma (IMH) in a SARS-CoV-2 positive patient.2 The
author1 suggests a combination of different patho-
physiologic mechanisms of aortic injury in these pa-
tients, which is undoubtedly an interesting aspect to
consider in the ever-growing association between
SARS-CoV-2 infection and vascular disease.3 In the
clinical setting, SARS-CoV-2 is associated with hyper-
coagulability leading to peripheral arterial and venous
thrombosis, but some aortic phenomena have been
described as well.3,4
Historically, acute aortic syndromes and mostly IMHs
have been associated with vasa vasorum degeneration
and/or rupture.5 Roncati et al suggest a SARS-CoV-2-
related vasa vasorum “endotheliitis” driven by the innate
and adaptive immune systems and also involving
platelet activation. This immunothrombosis ultimately
